Literature DB >> 33540594

Exosomes and Extracellular Vesicles in Myeloid Neoplasia: The Multiple and Complex Roles Played by These "Magic Bullets".

Simona Bernardi1,2, Mirko Farina1,2.   

Abstract

Extracellular vesicles (exosomes, in particular) are essential in multicellular organisms because they mediate cell-to-cell communication via the transfer of secreted molecules. They are able to shuttle different cargo, from nucleic acids to proteins. The role of exosomes has been widely investigated in solid tumors, which gave us surprising results about their potential involvement in pathogenesis and created an opening for liquid biopsies. Less is known about exosomes in oncohematology, particularly concerning the malignancies deriving from myeloid lineage. In this review, we aim to present an overview of immunomodulation and the microenvironment alteration mediated by exosomes released by malicious myeloid cells. Afterwards, we review the studies reporting the use of exosomes as disease biomarkers and their influence in response to treatment, together with the recent experiences that have focused on the use of exosomes as therapeutic tools. The further development of new technologies and the increased knowledge of biological (exosomes) and clinical (myeloid neoplasia) aspects are expected to change the future approaches to these malignancies.

Entities:  

Keywords:  AML; CML; MPNs; exosomes; extracellular vesicles; hematological malignancies; leukemia; myeloid neoplasia

Year:  2021        PMID: 33540594      PMCID: PMC7912829          DOI: 10.3390/biology10020105

Source DB:  PubMed          Journal:  Biology (Basel)        ISSN: 2079-7737


  162 in total

1.  Familial aggregation of acute myeloid leukemia and myelodysplastic syndromes.

Authors:  Lynn R Goldin; Sigurdur Y Kristinsson; Xueying Sharon Liang; Asa R Derolf; Ola Landgren; Magnus Björkholm
Journal:  J Clin Oncol       Date:  2011-12-12       Impact factor: 44.544

Review 2.  How we manage adults with myelodysplastic syndrome.

Authors:  Pierre Fenaux; Uwe Platzbecker; Lionel Ades
Journal:  Br J Haematol       Date:  2019-09-30       Impact factor: 6.998

3.  Exosomes derived from imatinib-resistant chronic myeloid leukemia cells mediate a horizontal transfer of drug-resistant trait by delivering miR-365.

Authors:  Qing-Hua Min; Xiao-Zhong Wang; Jing Zhang; Qing-Gen Chen; Shu-Qi Li; Xiao-Qing Liu; Jing Li; Jing Liu; Wei-Ming Yang; Yu-Huan Jiang; Yan-Mei Xu; Jin Lin; Qiu-Fang Gao; Fan Sun; Lei Zhang; Bo Huang
Journal:  Exp Cell Res       Date:  2017-12-06       Impact factor: 3.905

Review 4.  Exosomes: Therapy delivery tools and biomarkers of diseases.

Authors:  Lucio Barile; Giuseppe Vassalli
Journal:  Pharmacol Ther       Date:  2017-02-12       Impact factor: 12.310

5.  MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.

Authors:  Yana Pikman; Benjamin H Lee; Thomas Mercher; Elizabeth McDowell; Benjamin L Ebert; Maricel Gozo; Adam Cuker; Gerlinde Wernig; Sandra Moore; Ilene Galinsky; Daniel J DeAngelo; Jennifer J Clark; Stephanie J Lee; Todd R Golub; Martha Wadleigh; D Gary Gilliland; Ross L Levine
Journal:  PLoS Med       Date:  2006-07       Impact factor: 11.069

6.  Chronic Myeloid Leukemia Prognosis and Therapy: Criticisms and Perspectives.

Authors:  Domenico Russo; José Valentín Garcia-Gutierrez; Simona Soverini; Michele Baccarani
Journal:  J Clin Med       Date:  2020-06-02       Impact factor: 4.241

Review 7.  Hematological Malignancy-Derived Small Extracellular Vesicles and Tumor Microenvironment: The Art of Turning Foes into Friends.

Authors:  Ernesto Gargiulo; Jerome Paggetti; Etienne Moussay
Journal:  Cells       Date:  2019-05-27       Impact factor: 6.600

Review 8.  Functions of Exosomes in the Triangular Relationship between the Tumor, Inflammation, and Immunity in the Tumor Microenvironment.

Authors:  Tiantian Wang; Moussa Ide Nasser; Jie Shen; Shujuan Qu; Qingnan He; Mingyi Zhao
Journal:  J Immunol Res       Date:  2019-08-01       Impact factor: 4.818

Review 9.  Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An Update.

Authors:  Luana Bavaro; Margherita Martelli; Michele Cavo; Simona Soverini
Journal:  Int J Mol Sci       Date:  2019-12-05       Impact factor: 5.923

Review 10.  The Role of Exo-miRNAs in Cancer: A Focus on Therapeutic and Diagnostic Applications.

Authors:  Francesco Ingenito; Giuseppina Roscigno; Alessandra Affinito; Silvia Nuzzo; Iolanda Scognamiglio; Cristina Quintavalle; Gerolama Condorelli
Journal:  Int J Mol Sci       Date:  2019-09-21       Impact factor: 5.923

View more
  4 in total

Review 1.  Emerging role of exosomes in hematological malignancies.

Authors:  Sureshbabu Ram Kumar Pandian; Kevin Kumar Vijayakumar; Selvaraj Kunjiappan; Ewa Babkiewicz; Piotr Maszczyk
Journal:  Clin Exp Med       Date:  2022-07-07       Impact factor: 3.984

Review 2.  The Role of Exosomes in the Progression and Therapeutic Resistance of Hematological Malignancies.

Authors:  Haobing Wang; Yong You; Xiaojian Zhu
Journal:  Front Oncol       Date:  2022-05-26       Impact factor: 5.738

3.  Comparative Mutational Profiling of Hematopoietic Progenitor Cells and Circulating Endothelial Cells (CECs) in Patients with Primary Myelofibrosis.

Authors:  Mirko Farina; Simona Bernardi; Nicola Polverelli; Mariella D'Adda; Michele Malagola; Katia Bosio; Federica Re; Camillo Almici; Andrew Dunbar; Ross L Levine; Domenico Russo
Journal:  Cells       Date:  2021-10-15       Impact factor: 6.600

Review 4.  Extracellular Vesicles in Haematological Disorders: A Friend or a Foe?

Authors:  Ioanna Lazana
Journal:  Int J Mol Sci       Date:  2022-09-04       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.